Literature DB >> 3159525

Helper and suppressor T lymphocyte function in severe alcoholic liver disease.

U McKeever, C O'Mahony, C A Whelan, D G Weir, C Feighery.   

Abstract

The immune regulatory T cell status of patients with severe alcoholic liver disease (ALD) was investigated. Using monoclonal antibodies to identify lymphocyte subsets in 22 patients, a significant decrease in the percentage of T suppressor/cytotoxic cells (P less than 0.01) and increase in the percentage T helper/inducer population (P less than 0.05) was observed when the results were compared with 20 normal controls. However, when absolute numbers of these lymphocyte subsets were calculated the patient group did not differ significantly from the controls. Further studies revealed T immunoregulatory cell function to be normal. Concanavalin A induced suppressor cells resulted in equivalent inhibition of autologous cell mitogen responsiveness in the patient and control groups. In addition, purified patient T lymphocytes were demonstrated to provide normal help to and manifest normal suppression of IgG, IgA and IgM synthesis by allogeneic B cells. When spontaneous immunoglobulin synthesis by circulating mononuclear cells was investigated, a significant increase in IgA synthesis was found in the ALD patients (P less than 0.05). These results suggest that T cell immunoregulation is normal in patients with ALD and a defect in this system is not responsible for the increased synthesis of immunoglobulin observed in ALD.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159525      PMCID: PMC1577002     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

Review 1.  Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse.

Authors:  W K Lelbach
Journal:  Ann N Y Acad Sci       Date:  1975-04-25       Impact factor: 5.691

Review 2.  Alcohol and absorption from the small intestine. 1. Impairment of absorption from the small intestine in alcoholics.

Authors:  N Krasner; K M Cochran; R I Russell; H A Carmichael; G G Thompson
Journal:  Gut       Date:  1976-04       Impact factor: 23.059

3.  Serum immunoglobulins, complement component levels and autoantibodies in liver disease.

Authors:  R A Thompson; R Carter; R P Stokes; A M Geddes; J A Goodall
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

4.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

5.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Immunoglobulins in viral hepatitis and active alcoholic liver-disease.

Authors:  F I Lee
Journal:  Lancet       Date:  1965-11-20       Impact factor: 79.321

7.  Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease.

Authors:  R J Bailey; N Krasner; A L Eddleston; R Williams; D E Tee; D Doniach; L A Kennedy; J R Batchelor
Journal:  Br Med J       Date:  1976-09-25

8.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

Review 9.  Some immunological aspects of liver function.

Authors:  D R Triger
Journal:  Yale J Biol Med       Date:  1975-03

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  4 in total

1.  T-lymphocyte activation pathways in alcoholic liver disease.

Authors:  F Spinozzi; A Bertotto; F Rondoni; R Gerli; F Scalise; F Grignani
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production.

Authors:  J Deviere; J Content; C Denys; P Vandenbussche; L Schandene; J Wybran; E Dupont
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

3.  Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis.

Authors:  J Devière; C Denys; L Schandene; F Romasco; M Adler; J Wybran; E Dupont
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

4.  Defective suppression in the autologous mixed lymphocyte reaction in patients with Crohn's disease.

Authors:  D Kelleher; A Murphy; C A Whelan; C Feighery; D G Weir; P W Keeling
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.